SARS-CoV-2 infection can manifest many rashes. However, thrombotic
retiform purpura rarely occurs during COVID-19 illness. Aggressive
anti-COVID-19 therapy with a high-dose steroid regimen led to rapid
recovery. This immuno-thrombotic phenomenon likely represents a poor
type 1 interferon response and complement activation on the endothelial
surface in response to acute infection.